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Isotretinoinisthemosteﬀectivetreatmentforsevereacne,butthereareseveraladverseeﬀectsassociatedwithitsuse,someofthem
very exceptional (<1/10000). We report one case of hypoacusia and tinnitus in a 15-year-old boy treated with isotretinoin during
6 weeks, who quickly improved after isotretinoin withdrawal. Also, we comment other publications about hearing alterations in
patients treated with isotretinoin and other retinoids.
1.Introduction
Isotretinoin is the most eﬀective treatment for severe acne.
Several adverse eﬀects have been reported since its approval
by the Food and Drug Administration (FDA) in 1982.
Cheilitis and dry skin [1] are the most common, but
hearingalterationsareexceptional(<1/10000)[2].Wereport
one case of hypoacusia and tinnitus in a boy treated
with isotretinoin, who quickly improved after isotretinoin
withdrawal.
2.CaseReport
A 15-year-old boy with severe nodulocystic acne on his
face and back, who failed to respond to conventional
therapy, was treated by oral isotretinoin at a daily dose of
30mg (0.5mg/kg). At one month followup, the physical
examination only evidenced cheilitis and dry skin, and a
blood test was normal. Two weeks later, he started with
bilateral tinnitus and hypoacusia. There was no history of
previous trauma or other concomitant drug intake and
he denied fever, headache, dizziness, nausea, or vomiting.
Neurological examination was unremarkable.
The examination by an otorhinolaryngologist deter-
mined a normal eardrum and external ear conduct, a Rinne
testpositive,andaWebertestwithoutlateralization.Thever-
bal acumetric estimated a hearing loss of 45db according to
Fowler’s table, more evident for the words containing acute
vowels (i, e, a), which estimates losses from 500 to 3000Hz.
Due to a suspected diagnosis of isotretinoin-caused
ototoxicity, this drug was immediately discontinued and an
audiometry was requested. The patient reported a rapid
improvement after isotretinoin withdrawal, and the audiom-
etry made 15 days later only showed minimal alterations.
3. Discussion
Some studies have shown the inﬂuence of isotretinoin on
the ear. In 1988, in one of the 104 reports of suspected
adverse reactions to isotretinoin, Bidgy and Stern found
decreased hearing [3]. Nikiforidis et al. [4] found subclinical
changes in auditory brainstem response in 9% of the patients
treated during 3 weeks with isotretinoin and considered
reasonable suggest these subclinical changes may be due
to an isotretinoin-induced synaptic malfunction or to a
conduction defect in the auditory nerve ﬁbers. Also, a
prospective study of 32 patients found signiﬁcant modiﬁ-
cations in brainstem auditory and visual evoked potentials
after isotretinoin administration [5]. On the other hand,
a recent study of 38 patients with acne vulgaris treated
with isotretinoin found decreased hearing thresholds of the
patients after one, two, and three weeks of treatment [6].
In regard to other retinoids, one case of deafness with
acitretin was published [7]. This patient noticed sudden2 Case Reports in Medicine
bilateral sensorineural hearing loss with tinnitus after one
week of treatment, and she improved after reducing dose.
Otherwise, in a study of 12 cases of acitretin therapy for
hidradenitis suppurativa [8], one patient developed tinnitus
after 4 months with the treatment. Tinnitus disappeared
with the withdrawal, and repeated after reintroduction of
the treatment, and also developed headache and lack of
concentration, so treatment was discontinued.
Inourcase,therelationshipbetweenototoxicityandisot-
retinoin is probable with a score of 5 points with the
Naranjo probability scale [9]. The adverse event appeared
after isotretinoin was administered, improved when the drug
was discontinued, and there were no other causes of hearing
loss. We have not any objective evidence other than the
otologic examination, because the audiometry was made
when the patient had improved, two weeks after withdrawal.
If a patient treated with isotretinoin develops tinnitus
or deafness, it seems reasonable think that the drug could
induce nerve conduction alteration, so a complete explo-
ration including audiometry and auditory evoked potentials
could be indicated, but trying not to delay the withdrawal of
the drug.
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